Judith Bruchfeld

Publications
CV
Public outreach and news

Articles

Article: CLINICAL MICROBIOLOGY AND INFECTION. 2024;:S1198-743X(24)00121-6

Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe.

Günther G; Guglielmetti L; Kherabi Y; Duarte R; Lange C; Tuberculosis Network European Trials group; Adamides T; Akkerman O; Andersen AB; Bakos Á; Bjarnason A; Bruchfeld J; Chesov D; Codecasa LR; Cirillo D; Danilovits M; Davidavičienė E; Duarte R; De Souza Galvão ML; Garnier S; Gjocaj M; Günther G; Ibraim E; Kappnik M; Khachatryan N; Klimuk D; Kuksa L; Jachym MF; Josefsdottir K; Kaluzhenina A; Lange C; Mack U; Makek MJ; Manika K; Mclaughlin A-M; Mema D; Mengshoel AT; Muylle I; Nanovic Z; Özkara Ş; Perl S; Pesut D; Pierdou D; Ryskulov G; Skowroński M; Solovic I; Sukholytka M; Svetina P; Terleeva Y; Tiberi S; Togonidze T; Torri S; Turaev L; Usmanova R; Wirtz G; Vasankari T; Zhdanova E
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2024;140:62-69

Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment.

Wang S; Forsman LD; Xu C; Zhang H; Zhu Y; Shao G; Wang S; Cao J; Xiong H; Niward K; Schön T; Bruchfeld J; Zhu L; Alffenaar J-W; Hu Y
Article: PHARMACEUTICS. 2024;16(1):144

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis.

Dong S; Shao G; Davies Forsman L; Wang S; Wang S; Cao J; Bao Z; Bruchfeld J; Alffenaar J-WC; Liu J; Hu Y; Wu M
Article: CARDIOLOGY RESEARCH AND PRACTICE. 2023;2023:6687803-9

Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study.

Wu E; Mahdi A; Nickander J; Bruchfeld J; Mellbin L; Haugaa K; Ståhlberg M; Desta L
Article: SCIENTIFIC REPORTS. 2023;13(1):20230

Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study.

Mahdi A; Zhao A; Fredengren E; Fedorowski A; Braunschweig F; Nygren-Bonnier M; Runold M; Bruchfeld J; Nickander J; Deng Q; Checa A; Desta L; Pernow J; Ståhlberg M
Article: BMJ OPEN. 2023;13(10):e075383

Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort study.

Zheng X; Wang L; Davies Forsman L; Zhang Y; Chen Y; Luo X; Liu Y; Bruchfeld J; Hu Y; Alffenaar J-WC; Sha W; Xu B
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(10):729-741

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.

Visca D; Centis R; Pontali E; Zampogna E; Russell A-M; Migliori GB; Andrejak C; Aro M; Bayram H; Berkani K; Bruchfeld J; Chakaya JM; Chorostowska-Wynimko J; Crestani B; Dalcolmo MP; D'Ambrosio L; Dinh-Xuan A-T; Duong-Quy S; Fernandes C; García-García J-M; de Melo Kawassaki A; Carrozzi L; Martinez-Garcia MA; Martins PC; Mirsaeidi M; Mohammad Y; Naidoo RN; Neuparth N; Sese L; Silva DR; Solovic I; Sooronbaev TM; Spanevello A; Sverzellati N; Tanno L; Tiberi S; Vasankari T; Vasarmidi E; Vitacca M; Annesi-Maesano I
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(7):506-519

Clinical standards for the management of adverse effects during treatment for TB.

Singh KP; Carvalho ACC; Centis R; D Ambrosio L; Migliori GB; Mpagama SG; Nguyen BC; Aarnoutse RE; Aleksa A; van Altena R; Bhavani PK; Bolhuis MS; Borisov S; van T Boveneind-Vrubleuskaya N; Bruchfeld J; Caminero JA; Carvalho I; Cho JG; Davies Forsman L; Dedicoat M; Dheda K; Dooley K; Furin J; García-García JM; Garcia-Prats A; Hesseling AC; Heysell SK; Hu Y; Kim HY; Manga S; Marais BJ; Margineanu I; Märtson A-G; Munoz Torrico M; Nataprawira HM; Nunes E; Ong CWM; Otto-Knapp R; Palmero DJ; Peloquin CA; Rendon A; Rossato Silva D; Ruslami R; Saktiawati AMI; Santoso P; Schaaf HS; Seaworth B; Simonsson USH; Singla R; Skrahina A; Solovic I; Srivastava S; Stocker SL; Sturkenboom MGG; Svensson EM; Tadolini M; Thomas TA; Tiberi S; Trubiano J; Udwadia ZF; Verhage AR; Vu DH; Akkerman OW; Alffenaar JWC; Denholm JT
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023;67(5):e0170022-e01722

Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens.

Zhu Y; Zhu L; Davies Forsman L; Paues J; Werngren J; Niward K; Schön T; Bruchfeld J; Xiong H; Alffenaar J-W; Hu Y
Article: SCIENTIFIC REPORTS. 2023;13(1):4159

Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19.

Nickander J; Steffen Johansson R; Lodin K; Wahrby A; Loewenstein D; Bruchfeld J; Runold M; Xue H; Kellman P; Engblom H
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):246-258

Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.

Hedberg P; Granath F; Bruchfeld J; Askling J; Sjöholm D; Fored M; Färnert A; Naucler P
Article: BMC INFECTIOUS DISEASES. 2023;23(1):33

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.

Kjellberg A; Hassler A; Boström E; El Gharbi S; Al-Ezerjawi S; Kowalski J; Rodriguez-Wallberg KA; Bruchfeld J; Ståhlberg M; Nygren-Bonnier M; Runold M; Lindholm P
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1022090

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients.

Shao G; Bao Z; Davies Forsman L; Paues J; Werngren J; Niward K; Schön T; Bruchfeld J; Alffenaar J-W; Hu Y
Article: PLOS ONE. 2023;18(6):e0287341

COVID-19-related stigma among infected people in Sweden; psychometric properties and levels of stigma in two cohorts as measured by a COVID-19 stigma scale.

Reinius M; Svedhem V; Bruchfeld J; Holmström Larm H; Nygren-Bonnier M; Eriksson LE
Article: ISCIENCE. 2022;25(12):105652

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis.

Mousavian Z; Folkesson E; Fröberg G; Foroogh F; Correia-Neves M; Bruchfeld J; Källenius G; Sundling C
Article: BMJ OPEN. 2022;12(11):e061870

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.

Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2022;26(7):592-604

Clinical standards for drug-susceptible pulmonary TB.

Akkerman OW; Duarte R; Tiberi S; Schaaf HS; Lange C; Alffenaar JWC; Denholm J; Carvalho ACC; Bolhuis MS; Borisov S; Bruchfeld J; Cabibbe AM; Caminero JA; Carvalho I; Chakaya J; Centis R; Dalcomo MP; D Ambrosio L; Dedicoat M; Dheda K; Dooley KE; Furin J; García-García J-M; van Hest NAH; de Jong BC; Kurhasani X; Märtson AG; Mpagama S; Torrico MM; Nunes E; Ong CWM; Palmero DJ; Ruslami R; Saktiawati AMI; Semuto C; Silva DR; Singla R; Solovic I; Srivastava S; de Steenwinkel JEM; Story A; Sturkenboom MGG; Tadolini M; Udwadia ZF; Verhage AR; Zellweger JP; Migliori GB
Article: EUROPEAN RESPIRATORY JOURNAL. 2022;59(3):2101925

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Zheng X; Davies Forsman L; Bao Z; Xie Y; Ning Z; Schön T; Bruchfeld J; Xu B; Alffenaar J-W; Hu Y
Article: FRONTIERS IN PHARMACOLOGY. 2022;13:1032674

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis.

Zhang H; He Y; Davies Forsman L; Paues J; Werngren J; Niward K; Schön T; Bruchfeld J; Alffenaar J-W; Hu Y
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2021;27(12):1805-1813

Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study.

Hu Y; Zheng X; Davies Forsman L; Ning Z; Chen C; Gao Y; Zhang Z; Lu W; Werngren J; Bruchfeld J; Hoffner S; Xu B
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2021;59(12):e0137021-e01321

The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting.

Wikell A; Jonsson J; Dyrdak R; Henningsson AJ; Eringfält A; Kjerstadius T; Hålldin E; Baqir H; Kholod V; Sturegård E; Bruchfeld J; Schön T
Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3511-e3517

Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.

Kuhlin J; Davies Forsman L; Mansjö M; Jonsson Nordvall M; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schön T; Bruchfeld J
Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3520-e3528

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.

Zheng X; Bao Z; Forsman LD; Hu Y; Ren W; Gao Y; Li X; Hoffner S; Bruchfeld J; Alffenaar J-W
Article: PULMONOLOGY. 2021;27(5):403-412

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

Koirala S; Borisov S; Danila E; Mariandyshev A; Shrestha B; Lukhele N; Dalcolmo M; Shakya SR; Miliauskas S; Kuksa L; Manga S; Aleksa A; Denholm JT; Khadka HB; Skrahina A; Diktanas S; Ferrarese M; Bruchfeld J; Koleva A; Piubello A; Koirala GS; Udwadia ZF; Palmero DJ; Munoz-Torrico M; Gc R; Gualano G; Grecu VI; Motta I; Papavasileiou A; Li Y; Hoefsloot W; Kunst H; Mazza-Stalder J; Payen M-C; Akkerman OW; Bernal E; Manfrin V; Matteelli A; Mustafa Hamdan H; Nieto Marcos M; Cadiñanos Loidi J; Cebrian Gallardo JJ; Duarte R; Escobar Salinas N; Gomez Rosso R; Laniado-Laborín R; Martínez Robles E; Quirós Fernandez S; Rendon A; Solovic I; Tadolini M; Viggiani P; Belilovski E; Boeree MJ; Cai Q; Davidavičienė E; Forsman LD; De Los Rios J; Drakšienė J; Duga A; Elamin SE; Filippov A; Garcia A; Gaudiesiute I; Gavazova B; Gayoso R; Gruslys V; Jonsson J; Khimova E; Madonsela G; Magis-Escurra C; Marchese V; Matei M; Moschos C; Nakčerienė B; Nicod L; Palmieri F; Pontarelli A; Šmite A; Souleymane MB; Vescovo M; Zablockis R; Zhurkin D; Alffenaar J-W; Caminero JA; Codecasa LR; García-García J-M; Esposito S; Saderi L; Spanevello A; Visca D; Tiberi S; Pontali E; Centis R; D'Ambrosio L; van den Boom M; Sotgiu G; Migliori GB
Article: JOURNAL OF RHEUMATOLOGY. 2021;48(8):1243-1250

Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics.

Sundbaum JK; Arkema EV; Bruchfeld J; Jonsson J; Askling J; Baecklund E
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021;108:81-88

Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study.

Zhu J; Bao Z; Xie Y; Werngren J; Hu Y; Davies Forsman L; Bruchfeld J; Hoffner S
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2021;22(3):445-454

Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region.

Shedrawy J; Deogan C; Öhd JN; Hergens M-P; Bruchfeld J; Jonsson J; Siroka A; Lönnroth K
Article: EUROPEAN RESPIRATORY JOURNAL. 2021;57(3):2003463

Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.

Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar J-W; Schön T; Hu Y; Bruchfeld J
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021;87(3):1347-1358

Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study.

Gao Y; Davies Forsman L; Ren W; Zheng X; Bao Z; Hu Y; Bruchfeld J; Alffenaar J-W
Article: EUROPEAN RESPIRATORY JOURNAL. 2021;57(3):2002255

Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascade.

Nederby Öhd J; Hergens M-P; Luksha Y; Buxbaum C; Shedrawy J; Jonsson J; Bruchfeld J; Lönnroth K
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:727300

High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids.

Silva CS; Sundling C; Folkesson E; Fröberg G; Nobrega C; Canto-Gomes J; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Källenius G
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2020;1158:122397

Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.

Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar J-WC
Article: LAKARTIDNINGEN. 2020;117:20039

[Is it time to use sputum induction as a complementary specimen collection procedure in adult patients with suspected pulmonary tuberculosis?].

Kuhlin J; Tammelin A; Petersson J; Chryssanthou E; Tideholm-Nylén A; Schön T; Bruchfeld J
Article: INFECTIOUS DISEASES OF POVERTY. 2020;9(1):97

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study.

Zheng X-B; Diwan VK; Zhao Q; Hu Y; Bruchfeld J; Jiang W-L; Hoffner S; Xu B
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2020;96:390-397

Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.

Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
Article: TUBERCULOSIS. 2020;123:101959

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
Article: BMJ OPEN. 2020;10(6):e035350

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.

van den Elsen SH; Sturkenboom MG; Akkerman O; Barkane L; Bruchfeld J; Eather G; Heysell SK; Hurevich H; Kuksa L; Kunst H; Kuhlin J; Manika K; Moschos C; Mpagama SG; Muñoz Torrico M; Skrahina A; Sotgiu G; Tadolini M; Tiberi S; Volpato F; van der Werf TS; Wilson MR; Zúñiga J; Touw DJ; Migliori GB; Alffenaar J-W
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1900851

Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017.

Fröberg G; Jansson L; Nyberg K; Obasi B; Westling K; Berggren I; Bruchfeld J
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1901886

Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden.

Jonsson J; Kühlmann-Berenzon S; Berggren I; Bruchfeld J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2020;24(3):310-315

Latent tuberculosis in pregnant women: a patient perspective.

Jansson L; Shedrawy J; Lönnroth K; Bruchfeld J; Kulane A
Article: EUROPEAN RESPIRATORY JOURNAL. 2019;54(6):1901522

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Borisov S; Danila E; Maryandyshev A; Dalcolmo M; Miliauskas S; Kuksa L; Manga S; Skrahina A; Diktanas S; Codecasa LR; Aleksa A; Bruchfeld J; Koleva A; Piubello A; Udwadia ZF; Akkerman OW; Belilovski E; Bernal E; Boeree MJ; Cadiñanos Loidi J; Cai Q; Cebrian Gallardo JJ; Dara M; Davidavičienė E; Forsman LD; De Los Rios J; Denholm J; Drakšienė J; Duarte R; Elamin SE; Escobar Salinas N; Ferrarese M; Filippov A; Garcia A; García-García J-M; Gaudiesiute I; Gavazova B; Gayoso R; Gomez Rosso R; Gruslys V; Gualano G; Hoefsloot W; Jonsson J; Khimova E; Kunst H; Laniado-Laborín R; Li Y; Magis-Escurra C; Manfrin V; Marchese V; Martínez Robles E; Matteelli A; Mazza-Stalder J; Moschos C; Muñoz-Torrico M; Mustafa Hamdan H; Nakčerienė B; Nicod L; Nieto Marcos M; Palmero DJ; Palmieri F; Papavasileiou A; Payen M-C; Pontarelli A; Quirós S; Rendon A; Saderi L; Šmite A; Solovic I; Souleymane MB; Tadolini M; van den Boom M; Vescovo M; Viggiani P; Yedilbayev A; Zablockis R; Zhurkin D; Zignol M; Visca D; Spanevello A; Caminero JA; Alffenaar J-W; Tiberi S; Centis R; D'Ambrosio L; Pontali E; Sotgiu G; Migliori GB
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2019;23(11):1155-1161

Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis.

Schulman H; Niward K; Abate E; Idh J; Axenram P; Bornefall A; Forsgren S; Jakobsson J; Öhrling C; Kron M; Brudin L; Diro E; Getachew Kebede A; Paues J; Bruchfeld J; Wejse C; Stendahl O; Schön T
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2019;17(1):158

Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden.

Shedrawy J; Jansson L; Röhl I; Kulane A; Bruchfeld J; Lönnroth K
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(10):2341-2350

Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis.

Svensson RJ; Niward K; Davies Forsman L; Bruchfeld J; Paues J; Eliasson E; Schön T; Simonsson USH
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(8):1394-1402

Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades.

Forsman LD; Jonsson J; Wagrell C; Werngren J; Mansjö M; Wijkander M; Groenheit R; Hammar U; Giske CG; Schön T; Bruchfeld J
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2019;83:72-76

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O; Aleksa A; Alffenaar J-W; Al-Marzouqi NH; Arias-Guillén M; Belilovski E; Bernal E; Boeree MJ; Borisov SE; Bruchfeld J; Cadiñanos Loidi J; Cai Q; Caminero JA; Cebrian Gallardo JJ; Centis R; Codecasa LR; D'Ambrosio L; Dalcolmo M; Danila E; Dara M; Davidavičienė E; Davies Forsman L; De Los Rios Jefe J; Denholm J; Duarte R; Elamin SE; Ferrarese M; Filippov A; Ganatra S; Garcia A; García-García J-M; Gayoso R; Giraldo Montoya AM; Gomez Rosso RG; Gualano G; Hoefsloot W; Ilievska-Poposka B; Jonsson J; Khimova E; Kuksa L; Kunst H; Laniado-Laborín R; Li Y; Magis-Escurra C; Manfrin V; Manga S; Marchese V; Martínez Robles E; Maryandyshev A; Matteelli A; Migliori GB; Mullerpattan JB; Munoz-Torrico M; Mustafa Hamdan H; Nieto Marcos M; Noordin NM; Palmero DJ; Palmieri F; Payen M-C; Piubello A; Pontali E; Pontarelli A; Quirós S; Rendon A; Skrahina A; Šmite A; Solovic I; Sotgiu G; Souleymane MB; Spanevello A; Stošić M; Tadolini M; Tiberi S; Udwadia ZF; van den Boom M; Vescovo M; Viggiani P; Visca D; Zhurkin D; Zignol M; members of the International Study Group on new an
Article: ERJ OPEN RESEARCH. 2019;5(2):78-2019

A new mathematical model to identify contacts with recent and remote latent tuberculosis.

Fröberg G; Wahren Borgström E; Chryssanthou E; Correia-Neves M; Källenius G; Bruchfeld J
Article: BMC PUBLIC HEALTH. 2019;19(1):151

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study.

Wikell A; Åberg H; Shedrawy J; Röhl I; Jonsson J; Berggren I; Buxbaum C; Lönnroth K; Bruchfeld J
Article: JOURNAL OF INFECTION. 2019;78(1):35-39

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

Borisov SE; D'Ambrosio L; Centis R; Tiberi S; Dheda K; Alffenaar J-W; Amale R; Belilowski E; Bruchfeld J; Canneto B; Denholm J; Duarte R; Esmail A; Filippov A; Davies Forsman L; Gaga M; Ganatra S; Igorevna GA; Lazaro Mastrapa B; Manfrin V; Manga S; Maryandyshev A; Massard G; González Montaner P; Mullerpattan J; Palmero DJ; Pontarelli A; Papavasileiou A; Pontali E; Romero Leyet R; Spanevello A; Udwadia ZF; Viggiani P; Visca D; Sotgiu G; Migliori GB
Article: BMJ OPEN. 2018;8(9):e023899

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study.

Davies Forsman L; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar J-W; Mansjö M; Hoffner S; Xu B; Schön T; Bruchfeld J
Article: ARTHRITIS CARE & RESEARCH. 2018;70(10):1563-1567

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.

de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J; ARTIS Study Group
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2838-2845

Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting.

Niward K; Davies Forsman L; Bruchfeld J; Chryssanthou E; Carlström O; Alomari T; Carlsson B; Pohanka A; Mansjö M; Jonsson Nordvall M; Johansson AG; Eliasson E; Werngren J; Paues J; Simonsson USH; Schön T
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018;62(5):e00218

Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.

Niward K; Ek Blom L; Davies Forsman L; Bruchfeld J; Eliasson E; Schön T; Chryssanthou E; Paues J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2017;21(6):624-637

Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.

Lönnroth K; Mor Z; Erkens C; Bruchfeld J; Nathavitharana RR; van der Werf MJ; Lange C
Article: EUROPEAN RESPIRATORY JOURNAL. 2017;49(5):1700387

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Borisov SE; Dheda K; Enwerem M; Romero Leyet R; D'Ambrosio L; Centis R; Sotgiu G; Tiberi S; Alffenaar J-W; Maryandyshev A; Belilovski E; Ganatra S; Skrahina A; Akkerman O; Aleksa A; Amale R; Artsukevich J; Bruchfeld J; Caminero JA; Carpena Martinez I; Codecasa L; Dalcolmo M; Denholm J; Douglas P; Duarte R; Esmail A; Fadul M; Filippov A; Davies Forsman L; Gaga M; Garcia-Fuertes J-A; García-García J-M; Gualano G; Jonsson J; Kunst H; Lau JS; Lazaro Mastrapa B; Teran Troya JL; Manga S; Manika K; González Montaner P; Mullerpattan J; Oelofse S; Ortelli M; Palmero DJ; Palmieri F; Papalia A; Papavasileiou A; Payen M-C; Pontali E; Robalo Cordeiro C; Saderi L; Sadutshang TD; Sanukevich T; Solodovnikova V; Spanevello A; Topgyal S; Toscanini F; Tramontana AR; Udwadia ZF; Viggiani P; White V; Zumla A; Migliori GB
Article: PLOS ONE. 2017;12(11):e0187313

A borderline range for Quantiferon Gold In-Tube results.

Jonsson J; Westman A; Bruchfeld J; Sturegård E; Gaines H; Schön T
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):333-338

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
Article: EUROPEAN RESPIRATORY JOURNAL. 2015;46(6):1563-1576

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB-E; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go U-Y; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1212-1217

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J; ARTIS Study Group
Article: EUROPEAN RESPIRATORY JOURNAL. 2015;45(4):928-952

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K; Migliori GB; Abubakar I; D'Ambrosio L; de Vries G; Diel R; Douglas P; Falzon D; Gaudreau M-A; Goletti D; González Ochoa ER; LoBue P; Matteelli A; Njoo H; Solovic I; Story A; Tayeb T; van der Werf MJ; Weil D; Zellweger J-P; Abdel Aziz M; Al Lawati MRM; Aliberti S; Arrazola de Oñate W; Barreira D; Bhatia V; Blasi F; Bloom A; Bruchfeld J; Castelli F; Centis R; Chemtob D; Cirillo DM; Colorado A; Dadu A; Dahle UR; De Paoli L; Dias HM; Duarte R; Fattorini L; Gaga M; Getahun H; Glaziou P; Goguadze L; Del Granado M; Haas W; Järvinen A; Kwon G-Y; Mosca D; Nahid P; Nishikiori N; Noguer I; O'Donnell J; Pace-Asciak A; Pompa MG; Popescu GG; Robalo Cordeiro C; Rønning K; Ruhwald M; Sculier J-P; Simunović A; Smith-Palmer A; Sotgiu G; Sulis G; Torres-Duque CA; Umeki K; Uplekar M; van Weezenbeek C; Vasankari T; Vitillo RJ; Voniatis C; Wanlin M; Raviglione MC
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2015;4 Suppl 1:80-81

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. 2015;5(7):a017871

Tuberculosis and HIV Coinfection.

Bruchfeld J; Correia-Neves M; Källenius G
Article: PLOS ONE. 2015;10(4):e0123457

A sensitive urinary lipoarabinomannan test for tuberculosis.

Hamasur B; Bruchfeld J; van Helden P; Källenius G; Svenson S
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(6):3630-3632

Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(12):7557-7559

Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Schön T; Simonsson USH; Bruchfeld J; Larsson M; Juréen P; Sturegård E; Giske CG; Ängeby K
Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2014;190(10):1168-1176

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Sester M; van Leth F; Bruchfeld J; Bumbacea D; Cirillo DM; Dilektasli AG; Domínguez J; Duarte R; Ernst M; Eyuboglu FO; Gerogianni I; Girardi E; Goletti D; Janssens J-P; Julander I; Lange B; Latorre I; Losi M; Markova R; Matteelli A; Milburn H; Ravn P; Scholman T; Soccal PM; Straub M; Wagner D; Wolf T; Yalcin A; Lange C; TBNET
Article: PLOS ONE. 2014;9(4):e95159

Comparison between RFLP and MIRU-VNTR genotyping of Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011.

Jonsson J; Hoffner S; Berggren I; Bruchfeld J; Ghebremichael S; Pennhag A; Groenheit R
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2013;17(5):597-602

Completing treatment for latent tuberculosis: patient background matters.

Kan B; Kalin M; Bruchfeld J
Article: JOURNAL OF HOSPITAL INFECTION. 2013;83(4):321-326

Extensive nosocomial transmission of tuberculosis in a low-incidence country.

Jonsson J; Kan B; Berggren I; Bruchfeld J
Article: PLOS ONE. 2012;7(11):e43438

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.

Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2011;370(1-2):55-64

Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection.

Borgström E; Andersen P; Andersson L; Julander I; Källenius G; Maeurer M; Norrby M; Rosenkrands I; Tecleab T; Bruchfeld J; Gaines H
Article: TUBERCULOSIS. 2011;91(3):260-267

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.

Ruhwald M; Dominguez J; Latorre I; Losi M; Richeldi L; Pasticci MB; Mazzolla R; Goletti D; Butera O; Bruchfeld J; Gaines H; Gerogianni I; Tuuminen T; Ferrara G; Eugen-Olsen J; Ravn P; TBNET
Article: JOURNAL OF BACTERIOLOGY. 2011;193(3):670-678

African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Berg S; Garcia-Pelayo MC; Müller B; Hailu E; Asiimwe B; Kremer K; Dale J; Boniotti MB; Rodriguez S; Hilty M; Rigouts L; Firdessa R; Machado A; Mucavele C; Ngandolo BNR; Bruchfeld J; Boschiroli L; Müller A; Sahraoui N; Pacciarini M; Cadmus S; Joloba M; van Soolingen D; Michel AL; Djønne B; Aranaz A; Zinsstag J; van Helden P; Portaels F; Kazwala R; Källenius G; Hewinson RG; Aseffa A; Gordon SV; Smith NH
Article: PLOS ONE. 2011;6(1):e16647

Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden.

Sandegren L; Groenheit R; Koivula T; Ghebremichael S; Advani A; Castro E; Pennhag A; Hoffner S; Mazurek J; Pawlowski A; Kan B; Bruchfeld J; Melefors Ö; Källenius G
Article: PLOS ONE. 2010;5(5):e10893

Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden.

Ghebremichael S; Groenheit R; Pennhag A; Koivula T; Andersson E; Bruchfeld J; Hoffner S; Romanus V; Källenius G
Article: EUROPEAN RESPIRATORY JOURNAL. 2008;32(4):1023-1030

Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey.

Bothamley GH; Ditiu L; Migliori GB; Lange C; TBNET contributors
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2008;12(2):199-204

Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden.

Kan B; Berggren I; Ghebremichael S; Bennet R; Bruchfeld J; Chryssanthou E; Källenius G; Petersson R; Petrini B; Romanus V; Sylvan S; Kalin M
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2007;39(11-12):1045-1053

Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia.

Aderaye G; Bruchfeld J; Aseffa G; Nigussie Y; Melaku K; Woldeamanuel Y; Asrat D; Worku A; Gaegziabher H; Lebaad M; Lindquist L
Article: INFECTION. 2004;32(6):333-338

The relationship between disease pattern and disease burden by chest radiography, M. tuberculosis Load, and HIV status in patients with pulmonary tuberculosis in Addis Ababa.

Aderaye G; Bruchfeld J; Assefa G; Feleke D; Källenius G; Baat M; Lindquist L
Article: ACTA PAEDIATRICA. 2004;93(3):311-315

Detection of Mycobacterium tuberculosis in gastric aspirate and sputum collected from Ethiopian HIV-positive and HIV-negative children in a mixed in- and outpatient setting.

Berggren Palme I; Gudetta B; Bruchfeld J; Eriksson M; Giesecke J
Article: AIDS. 2003;17(3):435-440

Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia.

Aderaye G; Bruchfeld J; Olsson M; Lindquist L
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2002;21(11):1053-1061

Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis.

Palme IB; Gudetta B; Bruchfeld J; Muhe L; Giesecke J
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2002;40(5):1636-1643

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection.

Bruchfeld J; Aderaye G; Palme IB; Bjorvatn B; Ghebremichael S; Hoffner S; Lindquist L
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(5):331-337

Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics.

Bruchfeld J; Aderaye G; Palme IB; Bjorvatn B; Britton S; Feleke Y; Källenius G; Lindquist L
Article: EPIDEMIOLOGY AND INFECTION. 2001;127(3):517-525

A controlled estimate of the risk of HIV infection in Ethiopian children with tuberculosis.

Berggren Palme I; Gudetta B; Degefu H; Muhe L; Bruchfeld J; Giesecke J
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2001;20(11):1066-1072

Risk factors for human immunodeficiency virus infection in Ethiopian children with tuberculosis.

Palme IB; Gudetta B; Degefu H; Bruchfeld J; Muhe L; Giesecke J
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2001;45(1):41-52

Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine.

Hamasur B; Bruchfeld J; Haile M; Pawlowski A; Bjorvatn B; Källenius G; Svenson SB
Article: TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE. 2000;94(6):677-680

Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV.

Bruchfeld J; Aderaye G; Palme IB; Bjorvatn B; Källenius G; Lindquist L
Show more

All other publications

Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):548-562

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management.

Fedorowski A; Olsén MF; Nikesjö F; Janson C; Bruchfeld J; Lerm M; Hedman K
Letter: CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY. 2023;16(7):413-414

Microvasular Dysfunction and Reduced Cardiac Stress Reactivity in Postural Orthostatic Tachycardia Associated With Postacute COVID-19.

Mahdi A; Lodin K; Reistam U; Fedorowski A; Nygren-Bonnier M; Runold M; Bruchfeld J; Desta L; Pernow J; Nickander J; Ståhlberg M
Review: BRAIN CONNECTIVITY. 2023;13(4):178-210

European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19.

Crook H; Ramirez A; Hosseini A; Vavougyios G; Lehmann C; Bruchfeld J; Schneider A; D'Avossa G; Lo Re V; Salmoiraghi A; Mukaetova-Ladinska E; Katshu M; Boneschi FM; Håkansson K; Geerlings M; Pracht E; Ruiz A; Jansen JFA; Snyder H; Kivipelto M; Edison P
Corrigendum: JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB. 2022;25:72

Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].

Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC
Other: JACC: CASE REPORTS. 2021;3(4):573-580

Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience.

Johansson M; Ståhlberg M; Runold M; Nygren-Bonnier M; Nilsson J; Olshansky B; Bruchfeld J; Fedorowski A
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION. 2021;27(4):506-508

Long COVID-19-it's not over until?

Yelin D; Margalit I; Yahav D; Runold M; Bruchfeld J
Editorial comment: LANCET INFECTIOUS DISEASES. 2020;20(10):1115-1117

Long-term consequences of COVID-19: research needs.

Yelin D; Wirtheim E; Vetter P; Kalil AC; Bruchfeld J; Runold M; Guaraldi G; Mussini C; Gudiol C; Pujol M; Bandera A; Scudeller L; Paul M; Kaiser L; Leibovici L
Letter: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2020;24(4):461-463

Health-related quality of life among persons treated for tuberculosis in a European setting.

Shedrawy J; Jansson L; Bruchfeld J; Lönnroth K
Review: CLINICAL MASS SPECTROMETRY. 2019;14 Pt A:34-45

Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC
Letter: EUROPEAN RESPIRATORY JOURNAL. 2019;53(2):1801128

Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice.

Fröberg G; Jansson L; Bruchfeld J
Review: ERJ OPEN RESEARCH. 2019;5(1):115-2018

Biomarkers for tuberculosis: the case for lipoarabinomannan.

Correia-Neves M; Fröberg G; Korshun L; Viegas S; Vaz P; Ramanlal N; Bruchfeld J; Hamasur B; Brennan P; Källenius G
Editorial comment: EUROPEAN RESPIRATORY JOURNAL. 2019;53(1):1802077

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.

Rosales-Klintz S; Bruchfeld J; Haas W; Heldal E; Houben RMGJ; van Kessel F; Mandelbaum M; Matteelli A; Migliori GB; Oordt-Speets A; Solovic I; Vašáková M; Verver S; de Vlas SJ; Vonk Noordegraaf-Schouten MJM; de Vries G; Zenner D; van der Werf MJ
Review: JOURNAL OF INFECTION. 2018;77(6):469-478

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.

Pradipta IS; Forsman LD; Bruchfeld J; Hak E; Alffenaar J-W
Letter: EUROPEAN RESPIRATORY JOURNAL. 2017;49(4):1700173

Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.

Davies Forsman L; Bruchfeld J; Alffenaar J-WC
Letter: EUROPEAN RESPIRATORY JOURNAL. 2016;48(4):1230-1233

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

Zuur MA; Akkerman OW; Davies Forsman L; Hu Y; Zheng R; Bruchfeld J; Tiberi S; Migliori GB; Alffenaar J-WC
Letter: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2016;71(2):e51-e53

Viral Load and Risk of Tuberculosis in HIV Infection.

Lange C; van Leth F; Sester M; TBnet
Corrigendum: JOURNAL OF BACTERIOLOGY. 2012;194(6):1641

African 2, a Clonal Complex of Mycobacterium bovis Epidemiologically Important in East Africa (vol 193, pg 670, 2011)

Berg S; Garcia-Pelayo MC; Mueller B; Hailu E; Asiimwe B; Kremer K; Dale J; Boniotti MB; Rodriguez S; Hilty M; Rigouts L; Firdessa R; Machado A; Mucavele C; Ngandolo BNR; Bruchfeld J; Boschiroli L; Mueller A; Sahraoui N; Pacciarini M; Cadmus S; Joloba M; van Soolingen D; Michel AL; Djonne B; Aranaz A; Zinsstag J; van Helden P; Portaels F; Kazwala R; Kaellenius G; Hewinson RG; Aseffa A; Gordon SV; Smith NH
Review: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2011;15(1):24-31

Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection.

Houben RMGJ; Crampin AC; Ndhlovu R; Sonnenberg P; Godfrey-Faussett P; Haas WH; Engelmann G; Lombard CJ; Wilkinson D; Bruchfeld J; Lockman S; Tappero J; Glynn JR

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, Karolinska Institutet, 2016
Doctor Of Philosophy, Department of Medicine, Huddinge, Karolinska Institutet, 2002

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI